Sanofi Settles Inflammation-Drug Kickback Claims

Law360, New York (August 22, 2013, 1:43 PM EDT) -- Sanofi SA has agreed to pay $617,000 to resolve allegations that it defrauded Medicaid by paying doctors to buy and prescribe the anti-joint inflammation drug Hyalgan in violation of federal and state anti-kickback statutes, Maryland’s attorney general said Thursday.

Two U.S. units of the Paris-based drugmaker, Sanofi U.S. Services Inc. and Sanofi Aventis U.S. LLC, entered into the deal with Maryland and other states, the proceeds of which will fund state Medicaid programs.

"Drug companies that use bribes to boost their bottom lines show total disregard...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.